Cadila Healthcare: Is it the Right Time to Buy? | Surajit Pal's Technical Analysis | CNBC TV18

#HuntingForValue | Cadila Healthcare saw a 40% rally just in the span of a few months in 2017, but the enthusiasm failed to sustain & the stock is currently 25% off from its 52-week highs. What are the triggers for reversal? Watch Surajit Pal as he shares his funadamental analysis on the stock.

CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.